Abstract 14P
Background
Homologous recombination deficiency (HRD) is a clinically-proven indicator of sensitivity against platinum-based chemotherapy and PARP inhibitors in various malignancies, including ovarian cancers. Until now, HRD prediction has been carried out by detecting the deleterious mutations of the BRCA1 or BRCA2 gene or measuring genomic scar, i.e., scarHRD. However, the scarHRD method has limitations in applying tumors without matched germline data. Investigating HRD-specific transcriptomic signatures is one of the tangible approaches to predicting HRD in tumor-only samples. Although several RNA-seq-based HRD prediction algorithms have been developed, they support mainly cohort-wise classification regarding HRD status yet do not provide an equivalent value to scarHRD. The transformation into scarHRD from transcriptomic data would be highly valuable for clinical application and research use.
Methods
Here, we developed an algorithm of transcriptome-based HRD analysis, i.e., expHRD. The prediction model was established using the elastic net in TCGA-pan cancer training set. HRD geneset for applying expHRD calculation using single-sample geneset enrichment analysis was derived by bootstrap technique.
Results
expHRD is a clinically applicable RNA-seq-based HRD prediction platform in tumor-only samples. In clinic, expHRD can provide supportive information for predicting platinum or PARP inhibitor responses by providing predicted scarHRD score. We could extract the expHRD to analyze the inter-cohort evaluation, HRD-associated gene expression profile, mutations, or tumor types in samples without matched germline data, such as cryopreserved or formalin-fixed tissues, cell lines, or organoids.
Conclusions
Developing a targeted transcriptomic panel for calculating expHRD would be a cost-effective approach to linking our platform with the clinic.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
10P - An adapted CGP-based model to interpret POLE mutations in endometrial cancer
Presenter: Rita Trozzi
Session: Cocktail & Poster Display session
Resources:
Abstract
11P - Reconstructing tumour evolution of single cells using both somatic mutations and copy-number alterations
Presenter: Rija Zaidi
Session: Cocktail & Poster Display session
Resources:
Abstract
12P - Swiss-PO: Molecular modelling for precision oncology
Presenter: Fanny Krebs
Session: Cocktail & Poster Display session
Resources:
Abstract
13P - A novel algorithm for predicting variant detectability in oncogenomic analysis
Presenter: Alper Akkuş
Session: Cocktail & Poster Display session
Resources:
Abstract
15P - ClinBioNGS: An integrated clinical bioinformatics pipeline for the analysis of somatic NGS cancer panels
Presenter: Xavier Sole
Session: Cocktail & Poster Display session
Resources:
Abstract
16P - Investigation of c-MYC role in DNA-PK-mediated activation of STING pathway in SCLC
Presenter: Caterina de Rosa
Session: Cocktail & Poster Display session
Resources:
Abstract
17P - NRF2 activation promotes HER2-targeted tolerance and resistance in oesophageal adenocarcinoma through metabolic reprogramming to glutathione
Presenter: Wei Zhang
Session: Cocktail & Poster Display session
Resources:
Abstract
18P - AURKB inhibition radiosensitises NSCLC by altering mitotic fate
Presenter: Kathryn Egerton
Session: Cocktail & Poster Display session
Resources:
Abstract
19P - Stratified control study on neuroendocrine differentiation and potential clinical markers in patients with limited-stage small-cell lung cancer
Presenter: Li Liu
Session: Cocktail & Poster Display session
Resources:
Abstract
20P - Effects of <italic>Apis dorsata</italic> honey on the expression of selected CYP450, pro-apoptotic, and anti-apoptotic genes during induced cytotoxicity in cyclophosphamide-treated human lung carcinoma (A549) cells
Presenter: Jose Kenneth Narag
Session: Cocktail & Poster Display session
Resources:
Abstract